What is the recommended dosing regimen for an amiodarone (antiarrhythmic medication) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Infusion Dosing Regimen

The recommended dosing regimen for amiodarone infusion is 150 mg given over 10 minutes, which may be repeated if necessary, followed by a 1 mg/min infusion for 6 hours, then 0.5 mg/min for 18 hours, with a total dose over 24 hours not exceeding 2.2 g. 1, 2, 3

Initial Loading Dose

  • Administer 150 mg IV over 10 minutes as the initial loading dose 1, 2
  • This loading dose may be repeated in 10-30 minutes if necessary for inadequate response 3
  • The antiarrhythmic effect begins in less than 30 minutes after administration 3

Maintenance Infusion

  • Continue with 1 mg/min infusion for 6 hours (360 mg total) 1, 2, 3
  • Reduce to 0.5 mg/min for the next 18 hours (540 mg total) 1, 2, 3
  • Total dose over 24 hours should not exceed 2.2 g 1, 2, 4

Administration Considerations

  • Use a volumetric infusion pump for administration 4
  • For infusions longer than 1 hour, do not exceed amiodarone concentrations of 2 mg/mL unless a central venous catheter is used 4
  • Whenever possible, administer through a central venous catheter dedicated to that purpose 4
  • Use an in-line filter during administration 4
  • Amiodarone infusions exceeding 2 hours must be administered in glass or polyolefin bottles containing D5W 4

Monitoring Requirements

  • Continuous ECG monitoring is required during administration 3
  • Regular blood pressure monitoring is necessary to detect hypotension 3
  • Monitor for bradycardia and AV block during infusion 2, 3

Potential Adverse Effects

  • Hypotension, especially with rapid administration, is a common adverse effect 2, 3
  • Bradycardia and atrioventricular block may occur 2, 3
  • Phlebitis, particularly with concentrations >2 mg/mL, is a potential adverse effect 1, 3
  • Higher doses and faster infusion rates than recommended have resulted in hepatocellular necrosis and acute renal failure 4

Special Considerations

  • For patients with moderate or severe left ventricular failure, use with caution as amiodarone may cause negative inotropic effects 2
  • Amiodarone has a very long half-life (IV: 9-36 days; Oral: 26-107 days), which affects long-term management strategies 2, 3
  • Amiodarone has numerous drug interactions due to its effects on multiple ion channels and receptors 2
  • Concomitant use of other QT-prolonging medications should be done with caution 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amiodarone Dosage for Atrial Fibrillation with Rapid Ventricular Response

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.